From novel minimally invasive approaches in head and neck surgery for benign and malignant tumors to programs dedicated to voice preservation and recovery, restoring hearing, and managing sleep disorders, our otolaryngologists and laryngologists from Columbia and Weill Cornell Medicine offer patients diagnostic and therapeutic procedures that optimize functional and aesthetic outcomes.
Otolaryngology (ENT)
Featured Updates
Results from a new multi-center study, led by oncologists at NewYork-Presbyterian and Weill Cornell Medicine, has described for the first time a key biomarker – absolute lymphocyte count (ALC) – that has the potential to predict therapeutic response to chimeric antigen receptor (CAR) T-cell immunotherapy for patients with relapsed/refractory multiple myeloma. While this FDA-approved treatment is widely used, until now there has not been a way to predict whether B-cell maturation antigen (BCMA) CAR T-cell therapy would elicit a good response.
The Latest
Pediatric Neurology & Neurosurgery
Crossing Specialty Lines for Rare Genetic Neurocutaneous Conditions
